US Immunodeficiency Network News

7 / 20 / 2010 - The USIDNET Consortium has previously awarded travel scholarships to trainees and/or junior faculty

2010 ESID Travel Scholarship

The USIDNET Consortium has previously awarded travel scholarships to trainees and/or junior faculty working in Primary Immune Deficiency, to attend national and international meetings with strong emphasis on these diseases. USIDNET is currently interested in supporting two physicians/ scientists to attend the ESID meeting in Istanbul, Turkey October 6-9^th, 2010.

If you have submitted an abstract to this meeting and it will be presented, or if you are planning to submit an abstract for this meeting for the late breaker deadline (August 15^th), you may be interested in applying for this travel award.

Please see the ESID web site for more details about abstract submission: http://www.esid2010.org

Eligibility:

1. Trainees or Junior faculty within 5 years of their first faculty appointment, working in Primary Immune Deficiency in the United States

2. An accepted abstract at the ESID meeting.

Applications much include:

1. A letter of interest

2. A career statement

3. A curriculum vitae

4. The abstract submitted to the meeting

The travel grant is up to a maximum of $2500 for travel and living expenses.

All receipts must be kept and submitted in order to receive reimbursement.

Please submit your application sblotner@primaryimmune.org no later than August 16^th.

Awards will be made in September

7 / 1 / 2010 - For more information please visit: www.clinicaltrials.gov

ClinicalTrials.gov offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions. A clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.

ClinicalTrials.gov currently contains 92,124 trials sponsored by the National Institutes of Health, other federal agencies, and private industry. Studies listed in the database are conducted in all 50 States and in 173 countries ClinicalTrials.gov receives over 50 million page views per month 65,000 visitors daily.

The U.S. National Institutes of Health (NIH), through its National Library of Medicine (NLM), has developed this site in collaboration with the Food and Drug Administration (FDA), as a result of the FDA Modernization Act, which was passed into law in November 1997. See the FDA document - Guidance for Industry: Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions (March 2002).

You can learn more about this site from its Frequently Asked Questions and Factsheet.

This site complies to the HONcode standard for trustworthy health information: verify here.

ClinicalTrials.gov does not host or receive funding from advertising or from the display of commercial content.

Information for Investigators

For information on submitting studies to ClinicalTrials.gov, please see the information at http://prsinfo.clinicaltrials.gov.

Information for Webmasters

There is information available on linking to ClinicalTrials.gov from your web page.

Please read our Terms and Conditions regarding use of ClinicalTrials.gov data.

The Immune Deficiency Foundation (IDF) is pleased to announce that it has been awarded the grant "Resources to Assist Investigations in Primary Immunodeficiency Diseases" from the National Institutes of Health (NIH). This grant will allow IDF to continue to advance the detection, understanding, diagnosis and treatment of primary immunodeficiency diseases (PIDD) through their program, the United States Immunodeficiency Network (USIDNET).

"We are pleased to receive this grant that will allow us to continue the important work of USIDNET," said IDF president and founder Marcia Boyle. "IDF has been administering patient registries for primary immunodeficiencies supported by the NIH since 1992 and we are excited about the potential of the new patient-consented registries to dramatically improve the treatment of patients."

She is joined with the Co-Investigators Dr. Luigi Notarangelo, Children's Hospital Boston, Dr. Kathleen Sullivan, Children's Hospital of Pennsylvania and Dr. Jennifer Puck from the University of California, San Francisco.

About The Immune Deficiency Foundation

To learn more about USIDNET, visit www.usidnet.org

CONTACT: Jackie Sievers of The Immune Deficiency Foundation,
+1-443-632-2556

Web site: http://www.primaryimmune.org/

Read at BioSpace.com

5 / 7 / 2010 - Disease-Specific Working Groups

USIDNET is looking for volunteers for the Disease-Specific Working Groups.

For more information, please contact Project Manager Jacqueline Sievers at (443) 632-2556, or Registry Manager Shannon Blotner at (443) 632-2543.

4 / 14 / 2010 - Medical Affairs Scientific Director, Neurology/Immunology (Talecris)

Medical Affairs Scientific Director, Neurology/Immunology

Position Description The MA Scientific Director, Neurology/Immunology will provide medical affairs support for the neurology/immunology area including: 1) key opinion leader development, 2) education of internal and external health care providers and patient advocacy groups where appropriate, 3) development and execution of publication strategies, 4) scientific input into product strategic plans, 5) input into clinical plans and business development opportunities where appropriate, 6) initial input and review of promotional materials, 7) participation in and/or facilitation of speaker training meetings and advisory boards, 8) internal and external presentations to key stakeholders, and 9) general scientific issues related to the therapeutic area. This individual will serve as the therapy area/product expert to both internal and external customers, and will support both US and global initiatives.

Position Requirements MD required. Board certified or equivalent training in neurology with expertise in neuromuscular disorders, or allergy/immunology with expertise in treating Primary Immune Deficiencies. Minimum of 5 years experience in the pharmaceutical or biotech industry, or related work experience required. Medical affairs experience preferred.

Talecris offers a competitive salary and benefit package including 401(k) with company match, performance bonus and profit sharing. Recently voted to the Companies That Care, Talecris is proud of its work, life, balance programs and its generous tuition reimbursement program. We have the expertise, resources and established business infrastructure to develop, manufacture and market biotechnology products internationally. An Equal Opportunity Employer M/F/DV, Talecris Biotherapeutics is committed to enhancing and manufacturing cultural diversity within our work environment

To apply to this position please go to http://careers.peopleclick.com/careerscp/client_talecris/external_tbi/search.do and enter 4142 in the search by job ID field.

4 / 5 / 2010 - Focus: Primary Immune Deficiencies

Focus: Primary Immune Deficiencies

Award: $25,000 - 1 year award to fellows and junior faculty

Funding Period: July 2010 - June 2011

DEADLINE: June 15, 2010

CONTACT: Kate Sullivan sullivak@mail.med.upenn.edu

or Don Kohn DKohn@mednet.ucla.edu

Information: rarediseasenetwork.epi.usf.edu/PIDTC

3 / 30 / 2010 - Instituto da Criança ? Hospital das Clínicas da FMUSP November 28th to December 4th, 2010

Applicants should be MDs or graduate students of Biomedical and Biological Sciences. Up to fifty applicants will be accepted: 25 from Brazil and 25 from other countries. The School will cover all expenses related to air tickets, hotel accommodation and meals.

Application
50 positions will be offered for medical doctors and graduated students in Biology or Biomedical Sciences. Half of these positions (25) are reserved for applicants from abroad. The other half will be distributed among applicants from São Paulo metropolitan area (15 positions) and students from other Brazilian States, Federal District and other regions of São Paulo State (10 positions).

Who can apply?
Medical doctors in residency or fellowship training, or in MD/PhD programs;
Graduate students in Biology or Biomedical Sciences;
Post-doctoral researchers;
What requirements need to be fulfilled ?
Applicants should send to the Secretary of the ESPCA on Primary Immunodeficiences the following documents:
? Biographical sketch (maximum of two pages);
? An application letter justifying the application in terms of what the applicant expects from the course and how the course correlates with the applicant?s research and professional activities.
? A one-page description of the student?s research project;
? An official letter of recommendation written by the applicant?s advisor or hierarchical superior.
Dead line for applications: September 20th, 2010
Applications should send by e-mail to thais.scudelletti@icr.usp.br
Or by regular mail to:

Secretary of the ESPCA on Primary Immunodeficiences
Ms. Thais Scudelletti
Telephone 55 (11) 3069-8606
Instituto da Criança do HC-FMUSP
Av. Dr. Eneas Carvalho de Aguiar 647, 5º andar
05403-900, São Paulo, SP, BRAZIL

Applications will be selected by a faculty committee coordinated by Prof. Magda Carneiro-Sampaio and the list with the names of the accepted applicants will be announced on the course site by October, 1st, 2010.
A unique opportunity to explore the frontiers of Human Immunology
through the study of Primary Immunodeficiencies
Instituto da Criança do Hospital das Clínicas da FMUSP - Av. Dr. Enéas de Carvalho Aguiar, 647, São Paulo, Brazil
Telephone 55 (11) 3069-8606 | © 2010 - Todos os direitos reservados.

São Paulo Advanced School on Primary Immunodeficiencies:
Unraveling Human Immuno-Physiology